Pötter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, et al. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018;9(11):48–60. https://doi.org/10.1016/j.ctro.2018.01.001.
Article PubMed PubMed Central Google Scholar
Viswanathan AN, Thomadsen B, American Brachytherapy Society Cervical Cancer Recommendations Committee, American Brachytherapy Society. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachyther. 2012;11(1):33–46. https://doi.org/10.1016/j.brachy.2011.07.003.
Narayan K, van Dyk S, Bernshaw D, Khaw P, Mileshkin L, Kondalsamy-Chennakesavan S. Ultrasound guided conformal brachytherapy of cervix cancer: survival, patterns of failure, and late complications. J Gynecol Oncol. 2014. https://doi.org/10.3802/jgo.2014.25.3.206.
Article PubMed PubMed Central Google Scholar
van Dyk S, Kondalsamy-Chennakesavan S, Schneider M, Bernshaw D, Narayan K. Comparison of measurements of the uterus and cervix obtained by magnetic resonance and transabdominal ultrasound imaging to identify the brachytherapy target in patients with cervix cancer. Int J Radiat Oncol Biol Phys. 2014;88(4):860–5. https://doi.org/10.1016/j.ijrobp.2013.12.004.
Pötter R, Georg P, Dimopoulos JC, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol. 2011;100(1):116–23. https://doi.org/10.1016/j.radonc.2011.07.012.
Article PubMed PubMed Central Google Scholar
Mayr NA, Yuh WT, Zheng J, Ehrhardt JC, Sorosky JI, Magnotta VA, et al. Tumor size evaluated by pelvic examination compared with 3-D MR quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys. 1997;39(2):395–404. https://doi.org/10.1016/s0360-3016(97)00318-0.
Article CAS PubMed Google Scholar
Narayan K, Fisher R, Bernshaw D. Significance of tumor volume and corpus uteri invasion in cservical cancer patients treated by radiotherapy. Int J Gynecol Cancer. 2006;16(2):623–30. https://doi.org/10.1111/j.1525-1438.2006.00379.x.
Article CAS PubMed Google Scholar
Srivastava S, Saini SK, Dixit AK, Dwivedi D. Prognostic significance of tumor volume as determined on 3D ultrasound scan in uterine cervix cancer treated by radiotherapy. J Cancer Res Ther. 2017;13(2):324–8. https://doi.org/10.4103/0973-1482.183201.
Wang JZ, Mayr NA, Zhang D, Li K, Grecula JC, Montebello JF, et al. Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy. Cancer. 2010;116(21):5093–101. https://doi.org/10.1002/cncr.25260.
Article PubMed PubMed Central Google Scholar
Dimopoulos JC, Schard G, Berger D, Lang S, Goldner G, Helbich T, et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys. 2006;64(5):1380–8. https://doi.org/10.1016/j.ijrobp.2005.10.017.
Mayr NA, Taoka T, Yuh WT, Denning LM, Zhen WK, Paulino AC, et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2002;52(1):14–22. https://doi.org/10.1016/s0360-3016(01)01808-9.
Lindegaard JC, Fokdal LU, Nielsen SK, Juul-Christensen J, Tanderup K. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol. 2013;52(7):1510–9. https://doi.org/10.3109/0284186X.2013.818253.
Article CAS PubMed Google Scholar
Kirisits C, Lang S, Dimopoulos J, Berger D, Georg D, Pötter R. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys. 2006;65(2):624–30. https://doi.org/10.1016/j.ijrobp.2006.01.036.
Tanaka K, Umesaki N. Impact of three-dimensional (3D) ultrasonography and power doppler angiography in the management of cervical cancer. Eur J Gynaecol Oncol. 2010;31(1):10–7 (PMID: 20349774).
Alcázar JL, Jurado M. Three-dimensional ultrasound for assessing women with gynecological cancer: a systematic review. Gynecol Oncol. 2011;120(3):340–6. https://doi.org/10.1016/j.ygyno.2010.10.023.
Komatsu M, Teraya N, Natsume T, Harada N, Takeda K, Hamamoto R. Clinical application of artificial intelligence in ultrasound imaging for oncology. JMA J. 2025;8(15):18–25. https://doi.org/10.31662/jmaj.2024-0203.
Beriwal S, Demanes DJ, Erickson B, Jones E, De Los Santos JF, Cormack RA, et al. American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. Brachytherapy. 2012;11(1):68–75. https://doi.org/10.1016/j.brachy.2011.06.008.
Manea E, Chitoran E, Rotaru V, Ionescu S, Luca D, Cirimbei C, et al. Integration of ultrasound in image-guided adaptive brachytherapy in cancer of the uterine cervix. Bioeng. 2024;11(5):506. https://doi.org/10.3390/bioengineering11050506.
Comments (0)